1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (713) 745-9231
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Imatinib mesylate causes hypopigmentation in the skin
Article first published online: 8 OCT 2003
DOI: 10.1002/cncr.11812
Copyright © 2003 American Cancer Society
Additional Information
How to Cite
Tsao, A. S., Kantarjian, H., Cortes, J., O'Brien, S. and Talpaz, M. (2003), Imatinib mesylate causes hypopigmentation in the skin. Cancer, 98: 2483–2487. doi: 10.1002/cncr.11812
Publication History
- Issue published online: 17 NOV 2003
- Article first published online: 8 OCT 2003
- Manuscript Accepted: 27 AUG 2003
- Manuscript Revised: 13 AUG 2003
- Manuscript Received: 10 JUN 2003
REFERENCES
- 1, , , et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med. 1996; 2: 561–566.
- 2, . Imatinib mesylate—a new oral targeted therapy. N Engl J Med. 2002; 346: 683–693.
- 3, , , . The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol. 1998; 111: 233–238.
- 4, . SCF-KIT pathway in human epidermal melanocyte homeostasis. J Invest Dermatol. 1999; 113: 139–140.
- 5, , . Challenges in oncology. Case 3. Depigmentation in a chronic myeloid leukemia patient treated with STI-571. J Clin Oncol. 2002; 20: 869–870.
- 6, , , , . A novel KIT gene missense mutation in a Japanese family with piebaldism. J Invest Dermatol. 1998; 111: 337–338.
- 7, , , . A novel KIT mutation results in piebaldism with progressive depigmentation. J Am Acad Dermatol. 2001; 44: 288–292.
- 8, , , , . MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature. 1998; 391: 298–301.
- 9, , , et al. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev. 2000; 14: 301–312.
- 10, , , . Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin. Acta Derm Venereol. 1999; 79: 305–310.